Open Label Trial Assessing Safety and Efficacy of Burosumab (KRN23), in a Patient With ENS and Hypophosphatemic Rickets
Clinical trial NCT03581591 · COMPLETED
Trial details
- NCT number
- NCT03581591
- Sponsor
- Redwood Dermatology Sciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-31
- Primary completion
- 2019-12-06
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.